Evolus (EOLS) Change in Cash (2017 - 2026)
Evolus (EOLS) posted Change in Cash of -$4.0 million for Q1 2026, down 139.15% on a QoQ basis from $10.3 million in Q4 2025, and up 78.83% year-over-year from -$2.3 million in Q1 2025.
Evolus (EOLS) Change in Cash (2017 - 2026) Analysis & Trends
Evolus' Change in Cash history runs 10 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- Quarterly Change in Cash rose 78.83% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.1 million (up 37.72% YoY) and the FY2025 annual result came in at -$33.1 million, down 237.37% from the prior year.
- Change in Cash was -$4.0 million for Q1 2026 at Evolus, down from $10.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $34.1 million in Q1 2024 and bottomed at -$39.6 million in Q1 2022.
- A 5-year average of -$5.7 million and a median of -$6.2 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash sank 185.96% — and 2025, when it soared 437.45%.
- Evolus' Change in Cash stood at -$11.6 million in 2022, then soared by 307.32% to $24.2 million in 2023, then plunged by 92.06% to $1.9 million in 2024, then surged by 437.45% to $10.3 million in 2025, then sank by 139.15% to -$4.0 million in 2026.
- Business Quant data shows EOLS's Change in Cash at -$4.0 million in Q1 2026, $10.3 million in Q4 2025, and -$18.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.03 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | -18.22 Mn |
| Jun 30, 2025 | -6.16 Mn |
| Mar 31, 2025 | -19.06 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | -8.64 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | 34.12 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | -3.02 Mn |
| Jun 30, 2023 | 10.24 Mn |
| Mar 31, 2023 | -22.46 Mn |
| Dec 31, 2022 | -11.65 Mn |
| Sep 30, 2022 | -18.91 Mn |
| Jun 30, 2022 | -22.19 Mn |
| Mar 31, 2022 | -39.59 Mn |
| Dec 31, 2021 | 38.46 Mn |
| Sep 30, 2021 | -23.94 Mn |
| Jun 30, 2021 | 109.57 Mn |